Latest / Becker’s Healthcare Podcast / How Microbiome Science Is Advancing Personalized Care and Early Cancer Detection with Dr. Michael Bass
Transcript
- 0:00- This is Scott Becker with the Beckers HealthCare
- 0:03- podcast.
- 0:04- I'm thrilled today to be joined by a
- 0:06- brilliant
- 0:07- gastroenterologist
- 0:08- who's also a scientist,
- 0:10- who spends time
- 0:12- translating the microbiome
- 0:14- into clinical practice, the microbiome science. Doctor Bass,
- 0:18- you're... I know you're one of the original
- 0:21- founders or the founding medical director of OSHE
- 0:23- Health, which one of my
- 0:25- closest friends relies on so greatly and has
- 0:28- had just great results with. And and I
- 0:30- know you're now,
- 0:32- working as a leader, global medical director at
- 0:35- Viome.
- 0:36- Tell us about yourself and your career,
- 0:39- and how you got so deeply into the
- 0:41- microbiome space.
- 0:43- Definitely. First of all, Scott, it's a honor
- 0:46- to speak to you. I've been reading your
- 0:49- publication
- 0:50- for for probably going going on about fifteen
- 0:52- years right now. So thank you again
- 0:55- for having me on. But... So I'm a
- 0:57- I'm a practicing gastro doc in Delaware, and
- 1:00- a lot of the work I do grew
- 1:01- out of gaps I was seeing in everyday
- 1:03- clinical practice.
- 1:05- So that was especially true for patients with
- 1:07- functional gastro issues,
- 1:09- which are basically issues where there's no structural
- 1:11- damage like an ulcer or cancer.
- 1:14- But the problem is with how the gut
- 1:16- itself functions,
- 1:17- like IBS or irritable bowel syndrome.
- 1:21- So we would typically do all the tests
- 1:23- like an EEG, Colo, CAT scan,
- 1:26- MRIs. We'd rule out serious processes,
- 1:29- but we... We'd still had patients who wasn't
- 1:31- getting... Who were not getting better. So they
- 1:34- were coming back to us with the same
- 1:35- pain, the bloating or or bowel
- 1:38- issues. And we've done all the testing, but
- 1:40- we hadn't
- 1:42- necessarily helped them get their life back. So
- 1:45- that experience helped lead me to Oshi Health
- 1:47- where where I became the founding medical diet
- 1:50- director.
- 1:51- At Oshi, I helped build a model that
- 1:52- brings GI medical care, diet, and gut brain
- 1:56- health
- 1:57- with high touch support between visits.
- 2:00- So it addressed the gap that I was
- 2:02- seeing firsthand.
- 2:03- So Viome felt like a natural extension of
- 2:05- that work.
- 2:06- Once you're delivering more comprehensive care, the next
- 2:09- question is how to make that care more
- 2:12- personalized.
- 2:13- So two patients can have the exact same
- 2:16- gnosis, but very different underlying biology.
- 2:20- So can we get better info about those
- 2:22- differences and use it meaningfully?
- 2:25- So broadly, that's what we're trying to offer
- 2:27- doctors through ViomePro
- 2:28- where I currently serve as a global medical
- 2:30- diet director.
- 2:31- Our microbiome tests look at what the microbes
- 2:34- in your gut are actually doing,
- 2:36- and our goal is to make that info
- 2:38- useful
- 2:39- within an actual clinical
- 2:41- visit.
- 2:42- So our main distinction is the use of
- 2:44- metatranscriptomics.
- 2:46- So other stool microbiome companies use metagenomics,
- 2:50- which simply look at microbial
- 2:52- DNA.
- 2:53- So it tells us which organisms organisms
- 2:56- are present,
- 2:57- and what they could do, but doesn't tell
- 2:59- you exactly what they are doing. So metatranscriptomics
- 3:03- looks at the RNA.
- 3:05- So we can see which genes are actually
- 3:07- being expressed at the time of sampling,
- 3:10- and that tells us what they're actually doing.
- 3:13- But how we deliver that info to a
- 3:15- provider is equally important.
- 3:17- So a doc shouldn't have to become a
- 3:19- microbiome
- 3:20- researcher to use it. So some reports from
- 3:23- from other companies are 60 pages long and
- 3:26- give a long list of bacteria, but very
- 3:28- little help deciding what matters for the patient
- 3:31- that's sitting in front of you. So our
- 3:33- approach is to organize that info around functional
- 3:36- pathways and clinical context, giving a personalized nutrition
- 3:40- recommendations that could help manage current disease states
- 3:43- or even prevent those disease from occurring in
- 3:46- the first place. And that's powerful. For for
- 3:49- example, looking at gene expression related to methane
- 3:52- or or bile acid can help frame more
- 3:55- focused clinical talk about IBS.
- 3:57- So those findings still all need to be
- 3:59- in... Interpreted along the history and standard eval.
- 4:03- But I want us to bring more clarity
- 4:05- to a space that has been heavily shaped
- 4:07- by the wellness
- 4:08- industry.
- 4:09- So doctors have reasonable questions about what is
- 4:12- established and what remains uncertain,
- 4:14- but we need to answer those questions clearly.
- 4:17- So there are published studies reporting symptom improvement
- 4:20- with Viome's personalized new nutrition approach
- 4:23- including
- 4:24- IBS.
- 4:25- And and that's extremely encouraging, but we definitely
- 4:28- need more. So I want us focused on
- 4:30- symptoms, quality of life, and in general, better
- 4:33- clinical choices.
- 4:34- A better score on a report is only
- 4:36- useful if it translates into something meaningful for
- 4:39- the patient.
- 4:40- The other part of our work is earlier
- 4:42- cancer detection,
- 4:44- including cancer detect
- 4:46- pancreatic.
- 4:46- It's a blood test that measures enzymes made
- 4:49- by a pancreatic tumor called
- 4:52- proteases.
- 4:53- So these
- 4:54- proteases bury a hole in the in the
- 4:57- surrounding tissue and allow the cancer to actually
- 4:59- spread.
- 5:00- So we licensed the the underlying tech from
- 5:03- Oregon Health and Sciences University
- 5:05- and revalidated the data in our CLIA certified
- 5:08- lab.
- 5:09- So our val... Our validation data is promising
- 5:12- especially in early stage pancreatic cancer.
- 5:14- It's crucial because if you catch pancreatic cancer
- 5:17- in in early stage, the the five year
- 5:19- survival rate is forty four percent.
- 5:21- If it spreads, that rate drops down to
- 5:23- three percent.
- 5:25- So what ties all of this together for
- 5:27- me is the gap I foresaw in practice.
- 5:30- We need to do more with the information
- 5:31- we collect, whether that means personalized and care
- 5:34- for someone with persistent GI symptoms or pursuing
- 5:37- an earlier signal of pancreatic cancer, my work
- 5:40- is about helping doctors make a useful next
- 5:43- choice and making sure that choice helps the
- 5:45- patient.
- 5:47- I I wanna touch on two things that
- 5:48- you said, doctor Bass, and and just fascinating
- 5:51- body of research and work.
- 5:53- The first thing is... And this will be
- 5:55- a quick
- 5:56- issue discussion,
- 5:58- is you mentioned the 60 page report.
- 6:01- Is there anything more useless
- 6:04- than giving somebody who's busy a 60 page
- 6:06- report?
- 6:08- Scott, I I really cannot think of of
- 6:10- of a useful... Useless thing. I'm just... You
- 6:13- know, in in a in a standard clinical
- 6:16- visit, a doctor probably has ten or ten
- 6:18- or fifteen minutes with that patient.
- 6:20- So, I I mean, frankly, some of these
- 6:22- reports, it just creates more stress
- 6:25- stress for the patient, stress for the doctor
- 6:27- because the, you know, doctor feels the responsibility
- 6:30- of going over every aspect of that test.
- 6:34- So it it could actually be
- 6:37- detrimental to the actual care process.
- 6:40- No. A 100%.
- 6:41- And talk about... I mean, you're a great
- 6:45- constant learner. And and one of the beauties
- 6:47- of yourself is not just a practicing gastroenterologist,
- 6:51- but you're constantly trying to connect dots and
- 6:53- learn.
- 6:54- Talk to me about a few of the
- 6:57- most interesting things that you have learned
- 6:59- in the last several years. Like, what stands
- 7:01- out to you that was not... If not
- 7:03- an moment,
- 7:05- it could be a gradual moment,
- 7:07- but something that you learned about
- 7:09- the biome, that you learned about care, taking
- 7:12- care of patients
- 7:13- that really connected with you or resonated with
- 7:15- you? What are the few of the things
- 7:17- you've learned over the last several years that
- 7:18- really sort of were
- 7:20- instrumental in how you think about things?
- 7:23- Yeah. So, you know, when I finished,
- 7:25- fellowship... So so, you know, this is back
- 7:27- in 2014.
- 7:29- So, you know, I came I came right
- 7:31- out of standard standard medical training. So I
- 7:34- was a medical resident at Georgetown,
- 7:37- a, you know, fellow at
- 7:39- at SUNY Downstate.
- 7:40- And so we were given a very detailed
- 7:43- protocol about, you know, what should happen in
- 7:47- in standard clinical practice. So what tests we
- 7:49- should be ordering, what what imaging imaging studies
- 7:52- we should be getting.
- 7:54- So
- 7:56- when I actually started
- 7:57- practicing practicing on on my own, I saw
- 8:00- that a lot of the standard things we
- 8:02- were doing didn't didn't really work.
- 8:06- And, you know, so that's that's really kind
- 8:07- of prompted me to start to to start
- 8:10- thinking outside of the box.
- 8:12- You know, we're
- 8:13- in
- 8:14- in general great at telling you whether you
- 8:16- had cancer or or, you know, you know,
- 8:19- major structural problem.
- 8:21- But, you know, we're we're not great at
- 8:23- at prevention
- 8:25- and, you know, we're we're we're not great
- 8:27- at... In GI at least at at telling
- 8:30- you how do you manage
- 8:32- issues when when all of our standard test
- 8:34- test come out clear. So I mean, probably
- 8:36- probably one of the biggest moments for for
- 8:39- me was seeing that there... There's a lot
- 8:40- more work that needs to be done to
- 8:43- adequately treat patients in our field.
- 8:46- Thank you. And and and and talk for
- 8:48- a second about...
- 8:49- As you look towards 2027,
- 8:52- what are you most focused and excited about
- 8:54- as we head into this next year?
- 8:57- Yeah. So, I mean, as of now, currently,
- 8:59- there there are four trends that I'm that
- 9:01- I'm really watching closely. So first, it's the
- 9:03- it's the move towards combining different kinds of
- 9:06- patient data into personalized care. So we have
- 9:08- the medical
- 9:10- record, medication history labs, imaging studies. We have
- 9:13- wearables tracking sleep activity, heart rate, and even
- 9:17- glucose. So the genomic and and microbiome
- 9:20- data add a whole separate layer to that.
- 9:23- So this data helps care remove from being
- 9:26- reactive to preventative.
- 9:28- So
- 9:29- AI is beginning to help us interpret
- 9:32- those strengths altogether.
- 9:33- So so the broader opportunity is to identify
- 9:36- patterns over time and help clinicians
- 9:39- tailor follow-up or treatment.
- 9:41- So integrating all this reliably into routine care
- 9:44- is still an an evolving issue,
- 9:47- but I'm interested in systems that can tell
- 9:49- me what changed for the patient and how
- 9:51- that data really matters.
- 9:53- So second is care moving from doctors visits
- 9:57- and into the home. So remote monitoring makes
- 10:00- it possible to follow blood pressure, glucose, or
- 10:02- weight without waiting for your next appointment.
- 10:05- For for example, a a hypertension program can
- 10:08- use a series of home readings to to
- 10:10- support a medication review,
- 10:12- but the delivery model itself has to include
- 10:15- a team that reviews the info and a
- 10:17- clear threshold for contacting that patient. So that's
- 10:20- a step that actually turns a connected
- 10:22- device into into ongoing care. So the third
- 10:25- is AI becoming part of the clinical workflow.
- 10:28- So ambient
- 10:29- documentation is already being used to draft visit
- 10:32- notes and randomized trials are showing to... Are
- 10:35- beginning to measure the... Its effects on documentation
- 10:38- time and overall
- 10:39- clinician workload. So the next applications I'm watching
- 10:43- include chart prep, re... Full coordination,
- 10:46- and following up on incomplete tasks. For a
- 10:49- GI practice, that can mean helping the team
- 10:51- identify
- 10:53- missing prep
- 10:54- instructions or an unresolved
- 10:57- pathology follow-up. So I judge all of these
- 10:59- tools by the time, save the accuracy and
- 11:02- whether fewer patients fall through the cracks.
- 11:05- So fourth is the continued migration of per...
- 11:08- Procedures that we typically perform in the hospital
- 11:10- into the ASCs.
- 11:12- I think ortho and and and joints are
- 11:15- are are probably the biggest
- 11:17- example of this. Medicare's 2026 policies expanded the
- 11:21- the ASC covered
- 11:22- seizure list and the... And began removing
- 11:25- procedures from the inpatient only list.
- 11:28- So for operators, that creates real real opportunity,
- 11:31- but it also changes what the center needs
- 11:33- to do well. So patient selection and
- 11:36- estisia planning, home support, and follow-up become even
- 11:39- more important as as case complexity increases.
- 11:43- So, a successful outpatient ASC program has to
- 11:45- take responsibility
- 11:46- for the whole recovery process including the cleared
- 11:49- escalation plan when someone needs more help. So
- 11:52- I think centers that build that that capability
- 11:55- in will be in a strong spot.
- 11:57- Thank you. And and and love that. You've
- 11:59- had this great career as a physician, a
- 12:02- scientist,
- 12:03- a a lifelong learner.
- 12:05- What advice do you give to people coming
- 12:06- out of medical school today
- 12:09- about enjoying their career, thriving, having an impactful
- 12:13- career, leaning into it?
- 12:16- What advice would you have to
- 12:18- evolving physician, evolving leader?
- 12:21- Yeah, Scott. So so the first piece of
- 12:23- advice I would give is to stay close
- 12:25- to clinical practice for as long as you
- 12:27- can. So continuing to see patients really gives
- 12:29- me a perspective I wouldn't get from a
- 12:31- product meeting or leadership the discussions alone. So
- 12:35- it keeps me aware of what people are
- 12:37- actually struggling with and what a busy clinical
- 12:39- team can realistically do. So if your role
- 12:42- takes you out of practice,
- 12:43- both that contact into your schedule,
- 12:46- Sit in on clinics, re... Review patient messages,
- 12:49- and ask the staff where the processes keep
- 12:51- breaking down. When you're evaluating a a new
- 12:54- tool, follow one patient all the way through
- 12:56- it from ordering to the result to the
- 12:59- follow-up. So you'll learn a lot about whether
- 13:02- it works in in the real world.
- 13:05- Second, keep learning. So when I first moved
- 13:07- into digital health, I had to learn about
- 13:09- delivering care through a completely different model. It
- 13:12- was hard at first, and my old and
- 13:14- great tendencies kept drawing me back. And now
- 13:17- working in
- 13:19- a diagnostic field, this has required me to
- 13:21- understand more about underlying science and how evidence
- 13:24- becomes a clinical product. My medical training gave
- 13:27- me a a foundation, but each step required
- 13:29- a new skill set. So my practical advice
- 13:32- is to pick something important to your work
- 13:35- that you don't understand well enough. Spend time
- 13:37- with the person who actually does. Ask the
- 13:39- basic questions. If you're working with AI, learn
- 13:42- how the system is evaluated and where it
- 13:44- fails. If you're bringing a test into practice,
- 13:47- learn the difference between accurately measuring a signal
- 13:50- and showing how acting on that result actually
- 13:52- helps your patient.
- 13:54- And then finally, be willing to reinvent
- 13:56- yourself and reconsider how things should be done.
- 13:59- My my career moved in in directions I
- 14:02- wouldn't have predicted
- 14:03- because I kept following the problems I was
- 14:05- seeing in practice.
- 14:07- And that sometimes meant meant considering a model
- 14:09- outside the conventional
- 14:11- path for a GI doc.
- 14:13- So health care is changing quickly. And if
- 14:14- you're unwilling to learn or to question an
- 14:16- existing approach because it's worked for you in
- 14:18- the past, you will get left behind. So
- 14:21- just be flexible and have a clear reason
- 14:23- for what you believe and be willing to
- 14:25- change your mind when the evidence or experience
- 14:27- changes.
- 14:28- Stay committed to helping patients while remaining open
- 14:31- to a better way of doing it.
- 14:34- Doctor Bass, it's so inspiring to visit with
- 14:36- you. It it... It's truly a pleasure. I
- 14:38- love what you're doing.
- 14:39- I wanna thank you for joining us today
- 14:41- on the Becker's Healthcare Podcast. What an absolute
- 14:43- pleasure with a remarkable career. Thank you for
- 14:46- joining us. Scott, thank you so much.